Department of Biology, College of Natural Sciences, College of Medicine, Kyungpook National University, Deagu, Korea.
Int J Mol Med. 2010 Mar;25(3):315-20. doi: 10.3892/ijmm_00000347.
Congenital hearing loss (HL) is the most common sensory disorder in humans, affecting one in 1000 infants at birth. A high degree of genetic heterogeneity makes it difficult to screen for mutations in all known deafness genes in clinical applications. We have improved a genotyping microarray using the multiplex PCR-based allele-specific primer extension (ASPE) reaction and applied this method for the genetic diagnosis of congenital HL in Korea. Seven different mutations in the GJB2, SLC26A4 and mitochondrial 12S rRNA genes, which were identified on the basis of a previous study in a Korean population, were selected for the study. These genes were used to evaluate the accuracy of the microarray. The test for validation of the current version of HL genotyping microarray was fully concordant with the results of DNA sequencing in which 51 subjects with non-syndromic HL were originally genotyped. Furthermore, the blind test of the genotyping microarray detected four different mutations in 10 out of 65 patients, and the accuracy of microarray was calculated as 98% (64/65). Therefore, our results suggest that this HL genotyping microarray will be useful in clinical applications for the genetic diagnosis of HL.
先天性听力损失(HL)是人类最常见的感觉障碍,每 1000 名新生儿中就有 1 名受到影响。高度的遗传异质性使得在临床应用中难以筛选所有已知的耳聋基因的突变。我们使用基于多重 PCR 的等位基因特异性引物延伸(ASPE)反应改进了基因分型微阵列,并将该方法应用于韩国先天性 HL 的遗传诊断。根据之前在韩国人群中的研究,选择了 GJB2、SLC26A4 和线粒体 12S rRNA 基因中的 7 种不同突变进行研究。这些基因用于评估微阵列的准确性。当前版本的 HL 基因分型微阵列的测试与最初对 51 名非综合征性 HL 患者进行 DNA 测序的结果完全一致。此外,基因分型微阵列的盲测在 65 名患者中的 10 名中检测到了 4 种不同的突变,微阵列的准确性计算为 98%(64/65)。因此,我们的结果表明,这种 HL 基因分型微阵列将有助于 HL 的遗传诊断的临床应用。